Racetams were the first class of nootropics ever discovered, and remain one of the most popular nootropic substances on the planet. Why you ask? Find out more here.
Thoughts on a New Anti-Alzheimers Drug: Aducanumab
Nootropics for Preventing Alzheimers and Dementia
With an aging population, one of the major concerns is Alzheimers and other forms of Dementia, which unfortunalty has no cure. Alzheimers and dementia (AD), has become a major epidemic in North America. An estimated 1 in every 9 people over 65 in America have Alzheimers. World wide, nearly 44 million people have Alzheimers, or a similar dementia costing the world roughly 605 billion dollars [1]. In light of this, it has become increasingly important to find ways to prevent this disease before it arrives.